CareTrust REIT, Inc.

CareTrust REIT, Inc. (CTRE) Market Cap

CareTrust REIT, Inc. has a market capitalization of .

No quote data available.

CEO: David Sedgwick

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 2014-05-29

Website: https://www.caretrustreit.com

CareTrust REIT, Inc. (CTRE) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.

Analyst Sentiment

85%
Strong Buy

From 13 Active Polls

1Y Forecast: $44.50

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$42

Median

$45

High Bound

$47

Average

$45

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$44.50
▲ +6.10% Upside
Low Target
$42.00
0% Risk
Median Target
$44.50
6% Mid
High Target
$47.00
12% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CARETRUST REIT INC (CTRE) — Investment Overview

🧩 Business Model Overview

CARETRUST REIT Inc. is a healthcare-focused real estate investment trust that monetises ownership of post-acute healthcare properties through long-term lease arrangements with operating tenants. The value chain is straightforward: acquire or develop healthcare real estate, lease facilities on structured terms (often including rent steps/escalators and lease protections), and generate recurring rental cash flows that support distributions to shareholders. Tenant operating performance matters because it drives lease renewal behavior, timely rent payments, and the probability of lease restructuring rather than outright defaults.

💰 Revenue Streams & Monetisation Model

The primary revenue stream is rental income derived from healthcare facility leases. The monetisation model is designed to be recurring, with margin quality driven less by property “uptime” (as in traditional commercial real estate) and more by tenant credit and lease structure. Typical margin drivers include:

  • Lease term and rent escalators: contractual rent growth can translate into more durable AFFO/FFO generation than purely market-rate leasing.
  • Net lease characteristics: where applicable, the allocation of operating cost responsibility to tenants can reduce CARETRUST’s exposure to controllable property expenses.
  • Tenant and portfolio credit mix: higher-quality operators reduce default risk and lower the probability of disruptive lease resets.
  • Property-level capital intensity: the REIT’s ability to pass through required capital (or negotiate terms) influences long-run cash margins.

🧠 Competitive Advantages & Market Positioning

CARETRUST’s competitive edge is best understood through a healthcare REIT lens: credit underwriting and lease structuring create a “soft moat” that is difficult to replicate quickly at scale. Competitors can build portfolios, but matching underwriting discipline, tenant screening, and consistent leasing outcomes requires operational experience and access to credit-appropriate deal flow.

Moat Mechanism (Hard-to-copy): Credit culture + lease protections.
The durability of cash flows depends on the ability to select and structure leases with tenants operating in regulated healthcare markets. In practice, the moat is less about proprietary technology and more about building repeatable processes around tenant selection, documentation, collateral/guardrails, and remediation when performance deviates.

Competitive benchmarking:

  • Welltower (healthcare REIT): Broad exposure to senior housing and other care segments with significant scale. Welltower’s advantage is scale and diversification; CARETRUST generally focuses on a more healthcare-niche portfolio where lease underwriting and tenant specialization can be more decisive.
  • Omega Healthcare Investors (skilled nursing-focused REIT): Large footprint in skilled nursing with strong industry positioning. Omega’s scale is a competitive strength; CARETRUST differentiates through portfolio composition and tenant/lease structuring choices designed to manage operator credit risk.
  • Medical Properties Trust (hospital/acute-related REIT): More tied to hospital/acute care structures with different reimbursement dynamics. CARETRUST’s positioning is primarily tied to post-acute care facility demand and lease-based monetisation rather than acute-care reimbursement variability.

Industry focus contrast: CARETRUST’s emphasis on healthcare real estate where tenant performance and reimbursement environment drive lease outcomes leads to a positioning where underwriting discipline and lease design act as the primary barriers to sustained share gains by less-prepared competitors.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, CARETRUST’s growth outlook is supported by structural demand factors for post-acute care and by supply constraints in facility modernization. Key drivers include:

  • Aging demographics and care intensity: Growing demand for senior services and post-acute settings supports long-run occupancy fundamentals across the sector.
  • Behavioral health and specialty care demand: Expansion in outpatient and facility-based mental health care increases the addressable pool for healthcare real estate tied to those services.
  • Facility under-supply and capex cycles: Healthcare facilities require ongoing capital for regulatory compliance, patient experience standards, and operational upgrades; constrained supply supports pricing power at the lease level.
  • Operator consolidation and professionalisation: Consolidation among providers can create opportunities for sale-leaseback and portfolio optimisation, improving tenant quality over time when executed with disciplined screening.
  • Tenant retention and lease renewals: In healthcare, transitions are operationally complex; well-structured leases can reduce churn and support steadier cash generation.

⚠ Risk Factors to Monitor

  • Tenant credit and reimbursement sensitivity: Changes in Medicare/Medicaid reimbursement, staffing costs, and payer mix can pressure tenants, raising the probability of rent disruptions or restructurings.
  • Concentration risk: Portfolio exposure to specific sub-sectors of post-acute care or to a limited number of operators can amplify adverse events.
  • Interest rate and refinancing risk: Like many REITs, leverage and the cost of capital influence equity risk, especially during periods of tighter credit availability.
  • Capital expenditure requirements: Regulatory compliance and facility upgrades may be necessary even when lease economics are under pressure; the ability to shift or recoup capex affects returns.
  • Regulatory and legal risk: Healthcare regulations, reimbursement rules, and liability frameworks can alter operating viability for tenants, impacting lease performance.

📊 Valuation & Market View

Healthcare REIT valuations typically reflect cash-flow durability and balance sheet quality rather than pure property-level cap rates alone. Market frameworks often emphasize:

  • AFFO/FFO-based multiples: Reflects the recurring earnings power from leases and the expected path of cash generation.
  • Dividend sustainability: Investors commonly price the risk-adjusted ability to maintain and grow distributions over a cycle.
  • Balance sheet leverage and liquidity: Refinancing risk and interest coverage influence the discount applied to equity.
  • Lease rollover and credit quality: The probability of rent resets, re-leasing costs, and tenant remediation affects perceived value more than nominal growth.
  • Risk premiums for healthcare operating variability: Policy changes and operator performance typically drive multiple expansion/contraction across the sector.

🔍 Investment Takeaway

CARETRUST REIT’s long-term thesis rests on earning recurring cash flows from healthcare facility leases while leveraging its most defensible asset: credit underwriting and lease structuring discipline. In a sector where tenant viability is shaped by reimbursement, staffing economics, and regulatory requirements, the ability to select and manage tenants—and to structure leases that reduce downside—can function as a durable differentiator. The investment case strengthens when underwriting outcomes remain consistent and when portfolio cash flows demonstrate resilience through reimbursement and cost cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"CTRE reported Q1’26 results with Revenue of $142.8M and Net Income of $80.2M (EPS $0.36). On a QoQ basis, Revenue rose from $135.1M (Q4’25) to $142.8M (+5.7%), and Net Income increased from $111.3M (Q4’25) to $80.2M (-28.0%). YoY, Revenue grew from $71.6M (Q1’25) to $142.8M (+99.2%), and Net Income rose from $65.2M (Q1’25) to $80.2M (+22.9%). Profitability was strong in absolute terms but mixed sequentially: net margin was 56.2% in Q1’26, down from 82.4% in Q4’25 (margin contraction QoQ), though still below the very high Q1’25 level (91.8%). The income statement also shows higher interest income in Q1’26 ($22.0M) versus Q4’25 ($2.9M), supporting pre-tax earnings. Cash flow quality looked solid, with Operating Cash Flow of $90.4M and Free Cash Flow of $90.4M (CapEx $0) in the quarter. Shareholder returns appear supported by price momentum: CTRE’s 1-year market change is +38.0% with a small dividend yield (~0.9%), while the company paid $74.8M of dividends in Q1’26. Balance sheet resilience also improved: total assets rose to $5.24B and net cash remained (net debt ~-$223M)."

Revenue Growth

Strong

Revenue surged YoY to $142.8M (+99.2%) and increased QoQ from $135.1M (+5.7%), indicating a strong demand/earnings power inflection versus last year.

Profitability

Positive

Net income grew YoY (+22.9%) but fell QoQ (-28.0%). Net margin contracted sequentially (56.2% in Q1’26 vs 82.4% in Q4’25), suggesting less favorable quarter-specific items despite high levels of profitability.

Cash Flow Quality

Good

Operating Cash Flow was $90.4M and Free Cash Flow $90.4M in Q1’26, with dividends of $74.8M. OCF is healthy relative to net income, supporting cash-based earnings quality.

Leverage & Balance Sheet

Strong

Total assets increased to $5.24B and the balance sheet is net-cash (net debt ~-$223M). Equity is robust (~$4.14B), indicating strong financial resilience versus debt load.

Shareholder Returns

Good

Total return appears favorable given +38.0% 1Y price momentum and a ~0.9% dividend yield. Dividends were paid ($74.8M) but buybacks were not evident in Q1’26 (repurchases 0).

Analyst Sentiment & Valuation

Neutral

Consensus target implies some upside (target consensus ~$42.5 vs current ~$39.5, ~+7.6%). Valuation metrics (e.g., P/E ~25.5) suggest the stock is not deeply distressed, so execution must remain strong.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

CTRE delivered a strong Q1 2026 with normalized FFO up 38% YoY ($107.4M) and normalized FAD up 33% YoY ($107.6M), plus per-share growth (FFO +14%, FAD +12%). The business momentum is investment-led: $245M closed in Q1 at 8.8% blended stabilized yield, then another ~$865M closed since April at ~8.9% blended yield. Management highlighted quality outcomes—CMS performance in skilled nursing and very strong lease coverage in stabilized triple-net (2.25x EBITDAR; 2.79x EBITDARM) with 100% contractual rent/interest collections. Guidance was raised: midpoint normalized FFO per share +14.8% vs 2025 and normalized FAD per share +13.6% vs 2025, supported by 2.5% rent escalators and ~$145M loan repayments later in 2026. Key risks discussed center on competitive underwriting in SHOP and relationship-driven (more unpredictable) SNF sourcing. Capital is plentiful (investment grade upgrade, low leverage, revolver + ATM capacity), enabling continued deal selectivity.

AI IconGrowth Catalysts

  • Closed $245M investments in Q1 at 8.8% blended stabilized yield; anchored by a 6-property mid-Atlantic skilled nursing sale-leaseback at ~9% yield
  • Since April, closed 12 transactions totaling ~$865M at ~8.9% blended stabilized yield, accelerating quarterly investment pace
  • Second SHOP investment; total SHOP communities now 4, with continued disciplined, operator-centered expansion
  • UK care homes momentum: closed investments in 10 care homes since start of year; pipeline composition is over half UK care homes

Business Development

  • Sale-leaseback of a six-property mid-Atlantic skilled nursing portfolio leased to a quality operator (unnamed in transcript)
  • Opportunistic skilled nursing transaction with a new operating relationship (operator unnamed)
  • SHOP assisted living deal in Prescott, Arizona with a relationship operator known for a long time; Prescott is currently operated by that operator (units ~110, going-in year-one yield in the 8s)
  • Existing operator secured a small relationship-driven loan (facility operator not named)

AI IconFinancial Highlights

  • Normalized FFO: $107.4M (+38% YoY); normalized FAD: $107.6M (+33% YoY)
  • Normalized FFO per share: $0.48 (+14% YoY); normalized FAD per share: $0.48 (+12% YoY)
  • FFO per share guidance raised for 2026: midpoints imply +14.8% vs 2025 for normalized FFO per share and +13.6% vs 2025 for normalized FAD per share
  • G&A guidance increase: attributed almost entirely to hitting key KPI-based STI accruals plus catch-up accruals and incremental team build
  • Capital structure / coverage: stabilized triple-net portfolio EBITDAR rent coverage 2.25x; EBITDARM coverage 2.79x; collected 100% of contractual rent and interest in Q1
  • Cap rate compression: in SHOP, last six months cap rates compressed 50 bps or more (management cited ~“five handle” for Class A in primary markets)
  • Interest and rate sensitivity: interest income/expense movement due to revolver drawdown to fund acquisitions; guidance is a snapshot excluding future pipeline acquisitions

AI IconCapital Funding

  • ATM forward program: settled $129.5M gross proceeds under ATM forwards in Q1; additional forwards settled after quarter-end (exact remaining amount partially inaudible)
  • Balance sheet (May 7): $350M drawn on $1.2B unsecured revolver; ~$70M cash on hand
  • No scheduled debt maturities prior to 2028
  • Liquidity: ~$850M availability on revolver; ~$879M remaining ATM program capacity
  • Leverage: net debt/annualized run-rate EBITDA 0.6x; below long-term target 4x–5x range; net debt/enterprise value ~3.6%

AI IconStrategy & Ops

  • Pipeline discipline: company does not typically include larger portfolio pursuits in quoted pipeline; examples described include deals that materialize quickly or are not high-probability
  • Skilled nursing sourcing: predominantly off-market and relationship-driven; not reliant on consistent broker flow; higher yield deals increasingly require creativity
  • SHOP growth approach: competitive market; selectively bids—small percentage of deals become bids; only a smaller subset is ‘pushed and stretched’
  • UK platform: “by operators, for operators” culture attributed to London-based team; pipeline ahead of schedule and expected upside over time
  • Risk management re loans: lending done only when tied to real estate acquisitions or confident it leads to acquisitions; financing receivable accounting is cited as potentially misleading vs underlying deal economics

AI IconMarket Outlook

  • 2026 guidance (raised): normalized FFO per share range midpoints +14.8% vs 2025; normalized FAD per share midpoints +13.6% vs 2025
  • Key guidance assumptions: 2.5% inflation-based rent escalators on long-term triple-net; $145M of loans fully repaid during remainder of year; no material sterling-to-dollar spot exchange rate change; weighted avg diluted share count 234M
  • Capital markets outlook: management stated that if issuing debt this year, they expect USD-denominated issuance; indicative pricing for a ten-year implied by management at ~130–140 bps spread (exact note pricing not committed)

AI IconRisks & Headwinds

  • SHOP competition high: cap rate compression and competitive underwriting; low hit rate due to selectively bidding and choosing not to pursue most deals
  • Skilled nursing sourcing unpredictability: off-market relationship-driven environment; fewer buyers and fewer brokered opportunities for straightforward transactions
  • Guidance sensitivity: interest income/expense tied to timing of revolver draws; sterling-to-dollar exchange rate explicitly assumed unchanged in guidance

Q&A: Analyst Interest

  • Pipeline scope / larger portfolio evaluation: Management explained why larger portfolios are not included in the quoted pipeline—often lower-probability ‘fishing expeditions’—and gave a California example that materialized too quickly to include. They also noted deals can be passed on or redirected by sellers.
  • SHOP hit rate and cap-rate compression: Management described that only a small percentage of deals are bid on, and an even smaller share are ‘pushed and stretched.’ They cited that when stretching for desired deals, odds improve because they can stretch with cost-of-capital advantages; cap rates compressed 50 bps+ in six months.
  • Debt-market optionality after Moody’s upgrade: Analysts asked how investment grade benefits flexibility for larger opportunities, including possible inaugural high-grade issuance. Management said expanded access/optionality is real, with interest in deeper markets, potentially to ‘pad out’ the balance sheet as CTRE grows, subject to timing and objectives.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the CTRE Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — CareTrust REIT, Inc. (CTRE) Financial Profile